{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:51:44Z","timestamp":1776995504886,"version":"3.51.4"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158431","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T16:31:51Z","timestamp":1468513911000},"page":"e0158431","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection"],"prefix":"10.1371","volume":"11","author":[{"given":"Ming V.","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan E.","family":"Sise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Pavlakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth M.","family":"Amundsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Chute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna E.","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine M.","family":"Hanifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Gabardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Chandraker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliot C.","family":"Heher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahel","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo V.","family":"Riella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0b013e3181f92548","article-title":"Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand","volume":"90","author":"DR Scott","year":"2010","journal-title":"Transplantation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.transproceed.2009.01.074","article-title":"Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience","volume":"41","author":"L Santos","year":"2009","journal-title":"Transplant Proc"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ajkd.2003.09.018","article-title":"The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study","volume":"43","author":"IM Mahmoud","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/ajt.12847","article-title":"Effect of HCV, HIV and coinfection in kidney transplant recipients: mate kidney analyses","volume":"14","author":"Y Xia","year":"2014","journal-title":"Am J Transplant"},{"key":"ref5","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3748\/wjg.v20.i13.3410","article-title":"Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms","volume":"20","author":"LE Adinolfi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1681\/ASN.2010060668","article-title":"Effect of kidney transplantation on outcomes among patients with hepatitis C","volume":"22","author":"D Roth","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry","volume":"6","author":"S Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/01.tp.0000203554.54242.56","article-title":"Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis","volume":"81","author":"S Caillard","year":"2006","journal-title":"Transplantation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-199603270-00007","article-title":"A prospective study of hepatitis C virus infection in renal allograft recipients","volume":"61","author":"D Roth","year":"1996","journal-title":"Transplantation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jvh.12148","article-title":"Meta-analysis of observational studies: hepatitis C and survival after renal transplant","volume":"21","author":"F Fabrizi","year":"2014","journal-title":"J Viral Hepat"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/01.TP.0000131948.29742.24","article-title":"Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation","volume":"78","author":"A Bruchfeld","year":"2004","journal-title":"Transplantation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/TP.0b013e3182848de2","article-title":"Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta-analysis","volume":"95","author":"A Ingsathit","year":"2013","journal-title":"Transplantation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ki.2013.264","article-title":"Hepatitis C treatment in patients with kidney disease","volume":"84","author":"F Fabrizi","year":"2013","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1365-2036.2006.03151.x","article-title":"Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients","volume":"24","author":"F Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/j.1365-2893.2010.01405.x","article-title":"Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials","volume":"18","author":"F Fabrizi","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jmv.23919","article-title":"Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies","volume":"86","author":"F Fabrizi","year":"2014","journal-title":"J Med Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"AS Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0034-1371007","article-title":"New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development","volume":"34","author":"JM Pawlotsky","year":"2014","journal-title":"Semin Liver Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"AS Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.27366","article-title":"Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus","author":"EM Yoshida","year":"2015","journal-title":"Hepatology"},{"key":"ref22","article-title":"Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation","author":"N Kamar","year":"2015","journal-title":"Am J Transplant"},{"key":"ref23","article-title":"Successful treatment of Hepatitis C in renal transplant recipients with direct-acting antiviral agents","author":"D Sawinski","year":"2015","journal-title":"Am J Transplant"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-glycoprotein transport system and cardiovascular drugs","volume":"61","author":"JD Wessler","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11255-009-9594-1","article-title":"Collapsing glomerulopathy as a complication of interferon therapy for hepatitis C infection","volume":"42","author":"S Kanungo","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"ref26","first-page":"564","article-title":"Collapsing glomerulopathy after hepatitis C pegylated interferon treatment. Recovery of renal function with high-dose steroid treatment","volume":"3","author":"RH Berdichevski","year":"2010","journal-title":"NDT Plus"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"GS Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.27770","article-title":"Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant","volume":"61","author":"S Pungpapong","year":"2015","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/lt.24126","article-title":"Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients","volume":"21","author":"JA Gutierrez","year":"2015","journal-title":"Liver Transpl"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/1060028015576180","article-title":"Drug Interactions With Direct-Acting Antivirals for Hepatitis C: Implications for HIV and Transplant Patients","volume":"49","author":"S Burgess","year":"2015","journal-title":"Ann Pharmacother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2005.02502.x","article-title":"Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients","volume":"22","author":"JF Trotter","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref32","article-title":"Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A Phase 3 study (OPTIMIST-2)","author":"E Lawitz","year":"2015","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4\u20135 chronic kidney disease (the C-SURFER study): a combination phase 3 study","volume":"386","author":"D Roth","year":"2015","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:14:03Z","timestamp":1540026843000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158431"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,14]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158431","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,14]]}}}